CD47 and hepatocellular carcinoma: Accordingly, the blocking of CD47 was shown to enable macrophage-mediated phagocytosis of CSCs from pancreatic ductal adenocarcinoma (PDAC) [41], AML [42] and hepatocellular carcinoma (HCC) [43], and thus promotes their elimination.